MRSN - Financial Reports List - Mersana Therapeutics, Inc. - IntrinsicAlpha

Mersana Therapeutics, Inc. MRSN

Healthcare - Biotechnology - NASDAQ - US

$ 0.3269

-7.84 %

$ 40.7 M

Market Cap

-0.58

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	52.89%	27.77%	29.23%
Annual Report	FY	10-K	2024-12-31	9.88%	59.69%	57.10%
Quarterly Report	Q3	8-K	2024-09-30	63.65%	72.39%	71.03%
Quarterly Report	Q2	8-K	2024-06-30	-78.48%	55.31%	53.13%
Quarterly Report	Q1	8-K	2024-03-31	18.50%	66.22%	61.94%
Quarterly Report	Q4	8-K	2023-12-31	-27.14%	57.41%	54.61%
Annual Report	FY	10-K	2023-12-31	38.65%	17.28%	16.48%
Quarterly Report	Q3	8-K	2023-09-30	38.13%	30.35%	30.15%
Quarterly Report	Q2	8-K	2023-06-30	148.69%	-4.00%	-4.94%
Quarterly Report	Q1	8-K	2023-03-31	283.20%	-19.10%	-18.58%

1